When to Prefer Oral over IV for Osteomyelitis

Brad Spellberg argues trials support oral therapy when patient is stable, gut functioning, and oral agents cover pathogens.

Play episode from 10:56

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!